Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 110

    GST may lead to drug shortage; chemists not keeping stock: Kiran Mazumdar-Shaw, Biocon

    GST may lead to drug shortage; chemists not keeping stock: Kiran Mazumdar-Shaw, Biocon

    Ruby Khatun Khatun2 July 2017 9:36 AM IST
    New Delhi: Biotech major Biocon Chairman and Managing Director Kiran Mazumdar-Shaw today cautioned of possible drug shortage after implementation of...
    No price change in 78 percent of actively used drugs post GST: NPPA

    No price change in 78 percent of actively used drugs post GST: NPPA

    Ruby Khatun Khatun1 July 2017 4:07 PM IST
    New Delhi: Drug pricing regulator NPPA on Friday said prices of around 78 per cent of 'actively used' drugs will remain unaffected after the rollout...
    Fortis Healthcare gets shareholders nod to hike FIIs shareholding limit to 74 percent

    Fortis Healthcare gets shareholders nod to hike FIIs shareholding limit to 74 percent

    Ruby Khatun Khatun30 Jun 2017 1:07 PM IST
    New Delhi: Fortis Healthcare said its shareholders have approved increasing shareholding limit for foreign institutional investors to up to 74 per...
    Delhi High Court to hear pharma firms plea on fixed dose drugs ban

    Delhi High Court to hear pharma firms plea on fixed dose drugs ban

    Ruby Khatun Khatun30 Jun 2017 11:44 AM IST
    The Delhi High Court will today hear the plea filed by several pharmaceutical companies that sought a stay of a central government notification that...
    Columbia Asia to invest Rs 400 Crore on 2 new hospitals in India

    Columbia Asia to invest Rs 400 Crore on 2 new hospitals in India

    Ruby Khatun Khatun29 Jun 2017 3:53 PM IST
    New Delhi: International healthcare firm Columbia Asia will invest over Rs 400 crore to set up two new hospitals in India by the end of 2019 as it...
    DoP accepts Sun Pharmas review petition on Fucibet cream 15 gm AI tube while rejecting Histac EVT 2’s AI strip

    DoP accepts Sun Pharma's review petition on Fucibet cream 15 gm AI tube while rejecting Histac EVT 2’s AI strip

    Ruby Khatun Khatun29 Jun 2017 9:57 AM IST
    The Department of Pharmaceuticals (DoP) has accepted Sun Pharmaceutical's review petition against price fixation of “Fucibet cream 15 gm AI tube” and...
    Before GST, NPPA releases ceiling price of 761 medicines, Check out details

    Before GST, NPPA releases ceiling price of 761 medicines, Check out details

    Ruby Khatun Khatun28 Jun 2017 12:40 PM IST
    New Delhi: Drug price regulator NPPA on Tuesday announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and...
    Pharma Doyen, Lupin founder passes away

    Pharma Doyen, Lupin founder passes away

    Ruby Khatun Khatun27 Jun 2017 3:03 PM IST
    Mumbai: Dr Desh Bandhu Gupta, Founder and Chairman of Lupin Limited (Lupin), passed away early this morning in Mumbai. He was 79 years old. He will be...
    FDA approves betrixaban for the prophylaxis of venous thromboembolism in adult patients

    FDA approves betrixaban for the prophylaxis of venous thromboembolism in adult patients

    supriya kashyap kashyap27 Jun 2017 12:48 PM IST
    The U.S. Food and Drug Administration approved betrixaban (BEVYXXA, Portola) for the prophylaxis of venous thromboembolism (VTE) in adult patients...
    GST Trauma: Chemist Drop medicine storage, Temporary Shortage Likely

    GST Trauma: Chemist Drop medicine storage, Temporary Shortage Likely

    Meghna A Singhania26 Jun 2017 12:04 PM IST
    New Delhi: Uncertain about the impact of GST on their business, chemists across the country, seem to be turning down fresh inventories ahead of its...
    FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease

    FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease

    Ruby Khatun Khatun26 Jun 2017 9:16 AM IST
    The U.S. Food and Drug Administration approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to...
    Substandard: Nepal drugs watchdog asks Patanjali to recall six medicines

    Substandard: Nepal drugs watchdog asks Patanjali to recall six medicines

    Ruby Khatun Khatun25 Jun 2017 9:20 AM IST
    Kathmandu: Nepal's drugs watchdog has asked Ramdev's Patanjali Ayurveda to recall six Ayurvedic medicines after they were found to be of "substandard...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    Pharma Export do not need NOC: CDSCO

    Pharma Export do not need NOC: CDSCO

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok